Type 1 Diabetes Clinical Trials in Charlottesville, Virginia
10 recruitingCharlottesville, Virginia
Showing 1–10 of 10 trials
Recruiting
Phase 3
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Type 1 Diabetes Mellitus
Sanofi723 enrolled141 locationsNCT07088068
Recruiting
Phase 2
INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
Type 1 Diabetes Mellitus
Mannkind Corporation100 enrolled10 locationsNCT07224321
Recruiting
Not Applicable
A Randomized Parallel Clinical Trial of AIDANET, an Automated Insulin Delivery Algorithm, in Fully Closed-Loop Vs Hybrid Closed-Loop Mode In Adults With Type 1 Diabetes (AIDANET At Home)
Type 1 Diabetes
Sue Brown40 enrolled1 locationNCT07039617
Recruiting
Not Applicable
Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 Diabetes Using Automated Insulin Delivery
Type 1 Diabetes
Anas El Fathi6 enrolled1 locationNCT07212179
Recruiting
Phase 2
Evaluation of a Novel Insulin Sensitizer in People With Type 1 Diabetes
InsulinType 1 Diabetes (T1D)Glycemic Control for Diabetes Mellitus+2 more
University of Virginia40 enrolled1 locationNCT07186660
Recruiting
Not Applicable
Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes
Type 1 Diabetes
University of Virginia40 enrolled1 locationNCT05653518
Recruiting
Phase 2
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Type 1 Diabetes
SAb Biotherapeutics, Inc.159 enrolled65 locationsNCT07187531
Recruiting
Not Applicable
AIDANET Pediatrics
Type 1 Diabetes
Mark D. DeBoer, MD, MSc., MCR36 enrolled3 locationsNCT07020936
Recruiting
Not Applicable
Testing a Conversion Factor for a More Rapidly Acting Insulin in an Automated Insulin Delivery System Among Adolescents With T1D
Type 1 Diabetes
Mark D. DeBoer, MD, MSc., MCR20 enrolled1 locationNCT06948760
Recruiting
Not Applicable
Safety and Feasibility of a Machine-Learning Bolus Priming Added to Existing Control Algorithm
Type 1 Diabetes
Sue Brown16 enrolled1 locationNCT06728059